Oral compounds · Oral

Low-Dose Naltrexone

Also known as: LDN · Naltrexone (compounded low dose) · ReVia (parent drug)

What it is

Naltrexone is an opioid receptor antagonist. The low-dose variant typically refers to compounded preparations at a fraction of the standard dose.

How it works

At standard doses, competitively blocks mu-opioid receptors. The proposed low-dose mechanism involves transient opioid receptor blockade leading to compensatory upregulation of endogenous opioids and modulation of glial Toll-like receptor 4.

Where it's used

Standard-dose naltrexone is FDA-approved for opioid and alcohol use disorders. Low-dose use is off-label, studied in research for autoimmune and chronic pain conditions.

FDA-approved use

Standard-dose naltrexone is FDA-approved for opioid use disorder and alcohol use disorder. Low-dose use is off-label, typically via compounding pharmacies.

Tracking it

Low-Dose Naltrexone is oral, which makes consistency the whole game — a simple daily check-off with a reminder beats memory every time. with a half-life of about 4 hours, a dose log also lets a tracker model the relative amount still in your system between doses.

Source

OpenFDA

Not medical advice. This page is an educational summary compiled from public sources for people who log what they take. It is not a recommendation to use Low-Dose Naltrexone, a dosing guide, or a substitute for a clinician. How we source →

Last reviewed 2026-06-11